Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | immunoaffinity purified | 100 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | biotin conjugate | 100 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | Protein A purified | 500 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | Protein A purified | 100 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Orf1ab | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (Delta B.1.617.2 Variant) S RBD | monoclonal | Recombinant Human | SARS-CoV-2 (Delta B.1.617.2 Variant) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 RBD (Casirivimab biosimilar) | Casirivimab (REGN10933) | Recombinant | n/a | purified | 1mg, 5mg | n/a |
KMD BIOSCIENCE CO. LTD. |
More Info |
SARS-CoV-2 RBD (imdevimab biosimilar) | imdevimab (REGN10987) | Recombinant | n/a | purified | 1mg, 5mg | n/a |
KMD BIOSCIENCE CO. LTD. |
More Info |
Spike protein (RBD) | Sb#14 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#14 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#14 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#14 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#16 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#16 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#16 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#16 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#42 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#42 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#42 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#42 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#45 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#45 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#45 | Camelid | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
Spike protein (RBD) | Sb#45 | Camelid | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |